DURING the 31st Annual European Academy of Dermatology and Venereology (EADV) Congress, 7th–10th September 2022, held both in-person in Milan, Italy, and virtually, experts delivered a session on the topic of nail disorders. The session, chaired by Michela Starace, University of Bologna, Italy, and Stamatis Gregoriou, National and Kapodistrian University of Athens, Greece, explored the complexity of nail disease and anatomy, the impact of diet on nail health, nail disorders in childhood, and fungal nail infections. Gregoriou delivered an insightful, up-to-date talk on the best practices for management of distal lateral subungual onychomycosis (DLSO), supported by recent data from clinical studies and the European Nail Society (ENS).1

IMPROVING integrated healthcare across the country with the aid of digital innovation was a focus of the 9th annual Global Innovation and New Technology (GIANT) Health Event, which featured the UK National Integrated Care System (ICS) Congress, held on December 7th 2022 in London, UK. A session chaired by Debashish Das, St Bartholomew’s Hospital, Barts Health NHS Trust, London, UK, detailed the deployment of a virtual ward platform for patients awaiting elective cardiac surgery across seven cardiac surgery centres and one tertiary advanced cardiology centre in London. This session provided hope for the future of digital health solutions in healthcare.

No abstract

PROGRESSIVE multiple sclerosis (MS) posed an important topic of discussion at the 38th European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Congress, held in Amsterdam, the Netherlands, between 26th–28th October 2022. Throughout the engaging session on progressive MS, chaired by Kathy Smith, National Multiple Sclerosis Society, New York, USA, and Jan Meilof, University of Groningen, the Netherlands, key learning and focus points to consider for the future of clinical trials and treatments were summarised and spotlighted.

AT the 11 th European Conference on Rare Diseases (ECRD), held virtually between 27 th June and 1 st July as an official event of the 2022 French Presidency of the Council of the European Union (EU), experts discussed how invisibility in rare disease acts as a roadblock to reducing inequalities. The session, chaired by Ana Rath, Orphanet, French National Institute for Health and Medical Research (Inserm), France, provided insight into the inequalities, inequities, and injustice that people living with rare disease (PLWRD) face, referencing the United Nations (UN) Resolution on PLWRD 2021 1 and the UN Sustainable Development Goals (SDG). 2 The panel also highlighted how we can act at the local, regional, national, and global levels to bring rare diseases into focus, affect change, and start to bridge the inequality gaps.